NVUS - Novus Therapeutics Inc
Previous close
14.6
0 0%
Share volume: 3,155,914
Last Updated: Mon 04 Jan 2021 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$14.60
0.00
0.00%
Summary score
41%
Profitability
50%
Dept financing
3%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.36%
Return on assets
-18.08%
Return on sales
0%
Return on invested capital
168.87%
Total debt ratio
11.87%
Debt ratio change over timeo
-1%
Current Ratio
9.12%
Quick Ratio
0%
Cash Position Ratio
8.12%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-39.64%
Return on assets
-21.27%
Return on sales
0%
Return on invested capital
429.35%
Total debt ratio
12.49%
Debt ratio change over timeo
-1.03%
Current Ratio
7.72%
Quick Ratio
0%
Cash Position Ratio
6.92%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-27.64%
Return on assets
-20.01%
Return on sales
0%
Return on invested capital
724.37%
Total debt ratio
10.9%
Debt ratio change over time
-0.99%
Current Ratio
8.9%
Quick Ratio
0%
Cash Position Ratio
7.99%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.02%
Return on assets
-99.67%
Return on sales
0%
Return on invested capital
-7.99%
Total debt ratio
-99.58%
Debt ratio change over time
-1%
Current Ratio
-0.27%
Quick Ratio
0%
Cash Position Ratio
-0.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NVUS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -25.36% | 0% | 0% | 29.06% |
| Return on assets | -18.08% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 168.87% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 32% |
| Total debt ratio | 11.87% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 7.72% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 6.92% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 48% |
| Short-term ratios | NVUS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -39.64% | 0% | 0% | -16.12% |
| Return on assets | -21.27% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 429.35% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 6% |
| Total debt ratio | 12.49% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.03% | 0% | 0% | 0.09% |
| Dept financing | 4% | 0% | 0% | 50% |
| Current Ratio | 7.72% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 6.92% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 65% |